Information  X 
Enter a valid email address

Sensyne Health PLC (SENS)

  Print      Mail a friend

Monday 10 August, 2020

Sensyne Health PLC

Sensyne Health settles employment tribunal claim

RNS Number : 5706V
Sensyne Health PLC
10 August 2020

Sensyne Health

("Sensyne", the "Company" or the "Group")


Sensyne Health settles employment tribunal claim



Oxford, U.K. 10 August 2020: Sensyne Health plc (LSE: SENS), the Clinical AI technology company, today issues a statement regarding the settlement of an employment tribunal claim.


As previously announced, Lorimer Headley, left the Board and the business on 2 March 2020. He made allegations against the CEO, Lord Drayson. The Board arranged for these allegations to be investigated by an independent law firm and they found that the allegations were not supported by the evidence. The Board has decided, to avoid further legal costs and distraction for the business and in recognition of Mr Headley's contribution to Sensyne Health, to make a payment as compensation for loss of office to Mr Headley of £150,000 and a contribution of £200,000 towards his legal fees. As part of that settlement the Board has also agreed to provide outplacement assistance up to a value of £30,000. This constitutes full and final settlement of all claims in relation to his employment.


Following termination of his employment, Mr Headley also received a payment in lieu of his three-month contractual notice period and a payment in lieu of accrued but untaken holiday.


The compensation payment to Mr Headley constitutes a 'related party transaction' pursuant to Rule 13 of the AIM Rules for Companies. The directors consider, having consulted with Peel Hunt, the Company's nominated adviser, that the terms of the settlement are fair and reasonable insofar as shareholders are concerned.




For more information please contact:

Sensyne Health ( )

+44 (0) 330 058 1845

Lord (Paul) Drayson PhD FREng, Chief Executive Officer

Michael Norris, Interim Chief Financial Officer


Peel Hunt LLP (Nominated Adviser and Joint Broker)


+ 44 (0) 20 7418 8900

Dr Christopher Golden

James Steel

Oliver Jackson

Liberum (Joint Broker)

+ 44 (0) 20 3100 2000

Bidhi Bhoma

Euan Brown

Consilium Strategic Communications

+44 (0) 7780 600290

Mary-Jane Elliott

Sukaina Virji

Melissa Gardiner

[email protected]



About Sensyne Health  


Sensyne Health plc is a clinical AI company that works in partnership with the NHS to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).


For more information, please visit:


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t